Neusoft's NeuViz P10 with CZT Technology Elevates China's High-End Medical Equipment to Global Leadership in Photon-Counting CT
China's high-end medical equipment industry recently achieved a historic breakthrough. Neusoft Medical Systems, an innovative company within Neusoft Group, officially received marketing approval from the National Medical Products Administration (NMPA) for the NeuViz P10 cadmium zinc telluride (CZT) photon-counting CT system. This is not only China's first photon-counting CT system, but also the world's first 8cm wide-body photon-counting CT system. It marks China's transition from a laggard to a leader in next-generation CT technology, contributing a powerful "Chinese solution" to human health.
## Ten years of hard work and innovation in photon counting CT
The creation of the NeuViz P10 is deeply rooted in the nation's unwavering support for independent innovation in high-end medical equipment. The 14th Five-Year Plan identifies high-end medical imaging equipment as a key development area, vigorously promoting domestic substitution and addressing bottlenecks. The "Special Review Procedure for Innovative Medical Devices" established by the National Medical Products Administration (NMPA) also provided a key channel for the accelerated approval of the NeuViz P10.
From the start of preliminary research in 2016 to market approval in 2025, Neusoft Medical Systems has spent a decade building on its legacy, from developing China's first CT system 28 years ago to leading the world in photon-counting CT technology today. The "P" in NeuViz P10 stands for photon-counting detector, and the "10" symbolizes the profound accumulation of this decade of hard work.
## Disruptive technology: direct photon reading to reconstruct CT boundaries
The core innovation of the NeuViz P10 lies in its cadmium zinc telluride (CZT) photon counting detector, which completely revolutionizes the imaging principles of traditional CT. Conventional CT uses an energy integration model: X-rays -> scintillator crystals (convert to visible light) -> photodiodes (convert to electrical signals). The NeuViz P10 uses CZT semiconductor crystals to directly capture and read individual X-ray photons, achieving "direct photon reading." This delivers unprecedented ultra-high-definition, ultra-low-dose, and multi-energy imaging breakthroughs.
Based on a series of disruptive technologies, NeuViz P10 has created four major platforms: "Photon Counting", "Photon Ultrasonic", "Photon Intelligence" and "Photon Scientific Research", comprehensively reconstructing the accuracy, safety, speed, intelligence and scientific research of CT.
1. Reconstructing precise boundaries (photon ultra-high definition): Ultra-high resolution of 50 lp/cm is the core weapon.
2. Reconstructing the safety margin (low photon dose): Leveraging the "zero" electronic noise characteristic and the ClearInfinity algorithm, this technology significantly improves image quality while significantly reducing radiation dose and contrast agent usage, providing a safer imaging path for children, adolescents, pregnant women, and those with chronic diseases who require frequent examinations.
3. Reconstructing velocity boundaries (photon ultrasound): Equipped with a new-generation ultrasound platform and combined with iCMC (intelligent cardiac motion artifact correction) technology, it achieves 19ms ultra-high temporal resolution and full heart motion compensation, effectively suppressing motion artifacts and obtaining clear coronary artery images (with clearer display of stents, calcifications, and plaques) even under complex conditions such as high heart rate and arrhythmia.
4. Reconstructing the boundaries of intelligence (photonic intelligence): 17 AI technologies cover pre-scan intelligent planning, in-scan parameter control, post-scan deep learning reconstruction, and intelligent post-processing diagnosis, comprehensively improving efficiency and accuracy.
5. Reconstructing the boundaries of scientific research (photon spectroscopy): Routine multi-energy spectral imaging. This provides a powerful platform for research and precision medicine, including plaque composition analysis, tumor quantification and characterization, and drug metabolism tracking, empowering imaging omics and AI training.
At present, Neusoft Medical has cooperated with top tertiary hospitals such as Peking Union Medical College Hospital, West China Hospital of Sichuan University, the First Affiliated Hospital of China Medical University, and Beijing Tiantan Hospital Affiliated to Capital Medical University to carry out in-depth clinical and scientific research cooperation, jointly exploring the application potential of NeuViz P10 in complex diseases and accelerating its clinical value transformation.
## Chinese intelligent manufacturing takes the lead in entering the world stage
As the first Chinese company to master photon-counting CT technology, Neusoft has demonstrated that Chinese manufacturers are capable of not only catching up, but also keeping pace with, or even surpassing, their competitors. Especially in a complex international environment, independent control of high-end medical equipment means stable supply and the initiative in technological iteration, a crucial cornerstone of the nation's public health system and the health and safety of its citizens. The success of the NeuViz P10 is another significant achievement by Neusoft in fulfilling the national requirements for independent control of high-end medical equipment.
In the field of healthcare, Neusoft and its innovative subsidiaries continue to promote the deep integration of information technology and healthcare, and have built a six-in-one big health strategy covering medical digitization, medical equipment, health care services, medical services, financial insurance, and medical engineering talents. It is China's industry alliance with the most complete solutions in the field of digital health and the highest market share in the medical field.
As a leader and enabler of medical and health technology and business innovation, Neusoft has a keen insight into the development and changes in the medical industry. It uses intelligent strategies to fully unlock the infinite possibilities of the new medical era, uses artificial intelligence, big data and other information technologies to expand the new boundaries of AI+medicine, and enable high-quality development of the medical and health industry.
